Neutropenia, agranulocytosis and dipyrone

25Citations
Citations of this article
37Readers
Mendeley users who have this article in their library.

Abstract

Context: Neutropenia and agranulocytosis may be defined as granulocyte counts of less than 1,500/mm3 and 500/mm3, respectively. Agranulocytosis is a rare and serious disease often caused by drugs. It mortality rate is around 10%. The most common manifestations are infections such as tonsillitis, pharyngitis, stomatitis or pneumonia. Although dipyrone is one of the drugs known to be associated with agranulocytosis, the strength of the association has been a matter of much debate. Moreover, alternative analgesic and antipyretic agents are not devoid of serious side effects. Conclusions: It is therefore necessary to establish the incidence of agranulocytosis in Latin America and the role of dipyrone. The angoing LATIN Study is a multicenter international case-control study that will provide answers for these questions. Copyright © 2005, Associação Paulista de Medicina.

Cite

CITATION STYLE

APA

Hamerschlak, N., & Cavalcanti, A. B. (2005). Neutropenia, agranulocytosis and dipyrone. Sao Paulo Medical Journal. Associacao Paulista de Medicina. https://doi.org/10.1590/S1516-31802005000500009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free